Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled ‘A Phase 3, Randomized, ...
Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 2 Open-label Extension ...
WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer in ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Roberto Correa, a prostate cancer survivor, has found life-changing relief from incontinence thanks to new technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback